The vector of anti-BCMA chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human BCMA. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-BCM antibody linked to CD3-zeta and b2c signaling domains. And the vector product was designed for destroying multiple myeloma cells.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-CAR-LC25||Lenti-BCMA CAR (scFv-CD28, MM0108-3D44) Viral Particle|
|CAR-T-1-L335-G||Anti-BCMA scFv h(FcεRIγ) CART, pCDCAR1|
|CAR-T-2-L335-BZ||Anti-BCMA scFv h(41BB-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC29||Lenti-BCMA CAR (scFv-CD28-CD3ζ, MM0108-3D44) Viral Particle|
|CAR-ZP038||Anti-BCMA (bb21217) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-ZP002||Anti-BCMA (LCAR-B38M) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-T-2-L335-4Z||Anti-BCMA scFv h(CD4-CD3ζ) CART, pCDCAR1|
|CAR-T-1-L335-2||Anti-BCMA scFv h(CD28) CART, pCDCAR1|
|CAR-ZP001||Anti-BCMA (LCAR-B38M) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-ZP040||Anti-BCMA (BCMA-CART) h(CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved